The latest price target for Colgate-Palmolive (NYSE:CL) was reported by Piper Sandler on September 24, 2024. The analyst firm set a price target for $121.00 expecting CL to rise to within 12 months (a possible 16.50% upside). 48 analyst firms have reported ratings in the last year.

The latest analyst rating for Colgate-Palmolive (NYSE:CL) was provided by Piper Sandler, and Colgate-Palmolive initiated their overweight rating.

The last upgrade for Colgate-Palmolive Co happened on January 29, 2024 when Raymond James raised their price target to $91. Raymond James previously had a market perform for Colgate-Palmolive Co.

The last downgrade for Colgate-Palmolive Co happened on September 16, 2024 when Wells Fargo changed their price target from N/A to $100 for Colgate-Palmolive Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Colgate-Palmolive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Colgate-Palmolive was filed on September 24, 2024 so you should expect the next rating to be made available sometime around September 24, 2025.

While ratings are subjective and will change, the latest Colgate-Palmolive (CL) rating was a initiated with a price target of $0.00 to $121.00. The current price Colgate-Palmolive (CL) is trading at is $103.86, which is within the analyst’s predicted range.